Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MacroGenics, Inc. - Common Stock
(NQ:
MGNX
)
3.585
-0.015 (-0.42%)
Delayed Quote
Updated: 3:44 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MacroGenics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
MGNX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces That MacroGenics, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
July 30, 2024
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
July 29, 2024
From
The Schall Law Firm
Via
Business Wire
MACROGENICS, INC. (NASDAQ: MGNX) INVESTOR ALERT: Investors With Large Losses in MacroGenics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
July 29, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Expert Outlook: Macrogenics Through The Eyes Of 7 Analysts
↗
July 29, 2024
Via
Benzinga
Demystifying Macrogenics: Insights From 14 Analyst Reviews
↗
May 24, 2024
Via
Benzinga
Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
July 29, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
July 26, 2024
Via
Benzinga
MacroGenics to Participate in Upcoming Investor Conference
June 11, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
↗
May 25, 2024
Investors should take a close look at these biotech stocks as they position themselves to provide high returns.
Via
InvestorPlace
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
June 03, 2024
Via
Benzinga
MACROGENICS ALERT: Bragar Eagel & Squire, P.C. is Investigating MacroGenics, Inc. on Behalf of MacroGenics Stockholders and Encourages Investors to Contact the Firm
May 14, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against MacroGenics, Inc. (MGNX)
May 13, 2024
From
Kirby McInerney LLP
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 13, 2024
Via
Benzinga
MacroGenics to Participate in Upcoming Investor Conferences
May 13, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
Masters In Trading - Saturday, May 11
↗
May 11, 2024
In this recap of the most recent trading session, I discuss earnings results and the market rally seen throughout the past week.
Via
Talk Markets
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths'
↗
May 10, 2024
Despite MacroGenics' clinical activity, unexpected adverse events raise concerns. Analysts adjust ratings and price targets.
Via
Benzinga
Crude Oil Down 1%; Sweetgreen Shares Spike Higher
↗
May 10, 2024
Via
Benzinga
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday?
↗
May 10, 2024
A worse-than-expected University of Michigan’s May consumer report halted stock gains on Friday, sparking worries about a potential decline in consumer health amid perceived rising price pressures.
Via
Benzinga
Topics
Economy
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
May 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 10, 2024
Via
Benzinga
Nasdaq Moves Lower; US Consumer Sentiment Falls In May
↗
May 10, 2024
Via
Benzinga
MacroGenics Shares Tumble After Reporting Adverse Events, Multiple Deaths In Cancer Drug Trial
↗
May 10, 2024
Latest interim data from TAMARACK Phase 2 study by MacroGenics unveils insights into vobramitamab duocarmazine targeting B7-H3 in metastatic prostate cancer. Despite responses, notable safety concerns...
Via
Benzinga
Topics
Death
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors to Contact the Firm
May 10, 2024
From
Schall Law
Via
GlobeNewswire
Dow Jumps Over 100 Points; DNOW Posts Downbeat Earnings
↗
May 10, 2024
Via
Benzinga
Topics
Stocks
Why Is Progyny (PGNY) Stock Down 27% Today?
↗
May 10, 2024
Progyny stock is down on Friday after the company posted a revenue miss for Q1 and disappointed PGNY investors with its guidance!
Via
InvestorPlace
Why Natera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
↗
May 10, 2024
Via
Benzinga
Why Is Macrogenics (MGNX) Stock Down 69% Today?
↗
May 10, 2024
Macrogenics stock is down on Friday as MGNX investors react to clinical trial deaths and missed earnings for the first quarter of 2024.
Via
InvestorPlace
Topics
Death
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 10, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
May 10, 2024
The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!
Via
InvestorPlace
Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
May 10, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
